Literature DB >> 12401407

Formyl-peptide receptors revisited.

Yingying Le1, Philip M Murphy, Ji Ming Wang.   

Abstract

Leukocytes accumulate at sites of inflammation and microbial infection in direct response to locally produced chemotactic factors, which signal through specific G protein-coupled receptors. The first chemotactic factors to be structurally defined were the N-formyl peptides. Unlike other leukocyte chemoattractants, N-formyl peptides could originate from either an endogenous source, such as the mitochondrial proteins of ruptured host cells, or an exogenous source, such as the proteins of invading pathogens. This suggests that the formyl-peptide receptor (FPR) and its variant FPRL1 (FPR-like 1) are involved in host defense against bacterial infection and in the clearance of damaged cells. Recently, additional, more complex, roles for these receptors have been proposed because FPR, and to a greater extent FPRL1, have been found to interact with a menagerie of structurally diverse pro- and anti-inflammatory ligands associated with different diseases, including amyloidosis, Alzheimer's disease, prion disease and HIV. How these receptors recognize such diverse ligands, which are the most important in vivo, and how they contribute to disease pathogenesis and host defense are basic questions currently under investigation that could lead to new therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401407     DOI: 10.1016/s1471-4906(02)02316-5

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  197 in total

Review 1.  Chemoattractant receptors as pharmacological targets for elimination of glioma stem-like cells.

Authors:  Xiao-hong Yao; Ying Liu; Keqiang Chen; Wanghua Gong; Ming-yong Liu; Xiu-wu Bian; Ji Ming Wang
Journal:  Int Immunopharmacol       Date:  2011-09-17       Impact factor: 4.932

Review 2.  Brain-immune interactions and the neural basis of disease-avoidant ingestive behaviour.

Authors:  Gustavo Pacheco-López; Federico Bermúdez-Rattoni
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-12       Impact factor: 6.237

3.  The major leukocyte chemotactic and activating factors in the mouse gut lumen are not N-formylpeptide receptor 1 agonists.

Authors:  Teresa Ojode; Erich H Schneider; H Lee Tiffany; Sunny Yung; Ji-Liang Gao; Philip M Murphy
Journal:  J Innate Immun       Date:  2012-06-20       Impact factor: 7.349

Review 4.  New development in studies of formyl-peptide receptors: critical roles in host defense.

Authors:  Liangzhu Li; Keqiang Chen; Yi Xiang; Teizo Yoshimura; Shaobo Su; Jianwei Zhu; Xiu-wu Bian; Ji Ming Wang
Journal:  J Leukoc Biol       Date:  2015-12-23       Impact factor: 4.962

5.  Pharmacophore model for bile acids recognition by the FPR receptor.

Authors:  Cristina Ferrari; Antonio Macchiarulo; Gabriele Costantino; Roberto Pellicciari
Journal:  J Comput Aided Mol Des       Date:  2006-09-14       Impact factor: 3.686

6.  Rho GEF Lsc is required for normal polarization, migration, and adhesion of formyl-peptide-stimulated neutrophils.

Authors:  Sanjeev A Francis; Xun Shen; Jeffrey B Young; Prashant Kaul; Daniel J Lerner
Journal:  Blood       Date:  2005-11-01       Impact factor: 22.113

7.  Cross-desensitization of CCR1, but not CCR2, following activation of the formyl peptide receptor FPR1.

Authors:  Filip Bednar; Changcheng Song; Giuseppe Bardi; William Cornwell; Thomas J Rogers
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

Review 8.  Mitochondrial DNA in Sepsis.

Authors:  John S Harrington; Augustine M K Choi; Kiichi Nakahira
Journal:  Curr Opin Crit Care       Date:  2017-08       Impact factor: 3.687

9.  Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.

Authors:  Keqiang Chen; Mingyong Liu; Ying Liu; Teizo Yoshimura; Wei Shen; Yingying Le; Scott Durum; Wanghua Gong; Chunyan Wang; Ji-Liang Gao; Philip M Murphy; Ji Ming Wang
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

10.  Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.

Authors:  Liliya N Kirpotina; Andrei I Khlebnikov; Igor A Schepetkin; Richard D Ye; Marie-Josèphe Rabiet; Mark A Jutila; Mark T Quinn
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.